Phenotype - Genotype Correlation in a Sample of Egyptian Patients With Congenital Myopathies and Congenital Muscular Dystrophies

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-18
SponsorAin Shams University

About this trial

The aim of this study is to correlate the phenotype and genotype among a sample of Egyptian patients with Congenital myopathies and Congenital muscular dystrophies.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patients with clinical criteria of Congenital Myopathies (CMs) and Congenital Muscular dystrophies (CMDs) with different modes of inheritance.

Age: patients below age of 18 years.

Gender: Both males and females are included

Genetically confirmed CMs and CMDs.

Disqualifiers

Patients above 18 years.

Spinal muscular atrophy (SMA),and root lesions.

Congenital myasthenic syndromes

Dystrophinopathies,Duchenne Muscular Dystrophy (DMD), Limb-Girdle Muscular Dystrophy (LGMD)

Trial population

Descriptive Cross-sectional study was caried out on patients with suspected or confirmed congenital myopathies or congenital muscular dystrophies presenting to Ain Shams University Hospitals, recruited over a specific study period.

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

  • Genetic Testing and Muscle Biopsy

    Diagnostic test

    Comprehensive diagnostic assessment including clinical examination, electromyography (EMG), muscle biopsy for histopathological evaluation, and genetic testing to determine phenotype-genotype correlation in congenital myopathies and muscular dystrophies.

Treatment groups

25 Participants
are divided into 1 treatment group
Group A: Study Population1 intervention

Trial outcomes

Primary outcomes

1

Phenotype and genotype of congenital myopathies (CM) and congenital muscular dystrophies (CMD) patients

Correlation of the most common clinical presentations and complications among Egyptian patients with congenital myopathies (CM) and congenital muscular dystrophies (CMD) of different genotypes.

Time frame
Two years

Secondary outcomes

1

Common facial features

Identification and comparison of typical dysmorphic facial features associated with different genetic subtypes of congenital myopathies (CM) and congenital muscular dystrophies (CMD).

Time frame
Two years
2

Response to physiotherapy

Response to physiotherapy will be recorded.

Time frame
Two years
3

Prognosis of same genotype across different age groups

The prognosis of the same genotype across different age groups will be recorded.

Time frame
Two years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.